Martin, F. L., McKie, P. M., Sangaralingham, J. S., Ichiki, T., Harders, G. E., Chen, H. H., & Burnett, J. C. (2011). Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models of ardiorenal fibrosis. BioMed Central.

Martin, Fernando L., Paul M. McKie, Jeson S. Sangaralingham, Tomoko Ichiki, Gerald E. Harders, Horng H. Chen, and John C. Burnett. Cenderitide, a Novel Dual GC-A and GC-B Receptor Activator, Is a Potent Chronic Cardiorenal Fibroinhibiting Peptide Which Suppresses Aldosterone and Reduces Proteinuria in Models of Ardiorenal Fibrosis. BioMed Central, 2011.

Martin, Fernando L., et al. Cenderitide, a Novel Dual GC-A and GC-B Receptor Activator, Is a Potent Chronic Cardiorenal Fibroinhibiting Peptide Which Suppresses Aldosterone and Reduces Proteinuria in Models of Ardiorenal Fibrosis. BioMed Central, 2011.